# A Rollover Study For Subjects Discontinuing From UK-453,061 Studies For The Treatment Of HIV-1

> **NCT00824369** · PHASE2 · TERMINATED · sponsor: **Pfizer** · enrollment: 52 (actual)

## Conditions studied

- HIV-1

## Interventions

- **DRUG:** No drug will be administered

## Key facts

- **NCT ID:** NCT00824369
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-07
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 52 (ACTUAL)
- **Why stopped:** See termination reason in detailed description.
- **Last updated:** 2014-08-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00824369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00824369, "A Rollover Study For Subjects Discontinuing From UK-453,061 Studies For The Treatment Of HIV-1". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00824369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*